Formula & Concentration
CIMZIA (certolizumab pegol) Lyophilized powder or solution for subcutaneous use
CIMZIA is a tumor necrosis factor (TNF) blocker indicated for:
- Reducing signs and symptoms of Crohn’s disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy
- Treatment of adults with moderately to severely active rheumatoid arthritis
Shelf Life and Storage
- Refrigerate intact carton at 2° to 8° C (36° to 46° F). Do not freeze. Do not separate contents of carton prior to use. Do not use beyond expiration date, which is located on the drug label and carton.
- Protect solution from light.